Clinical Report: Survey on Real-World Interventions in Psoriasis Management

Overview

Revise to include details on patients not meeting targets and their treatment continuation.

Background

Plaque psoriasis is a chronic inflammatory condition that significantly impacts patients' quality of life. The introduction of biologic therapies has transformed treatment goals, yet many patients still do not achieve optimal skin clearance. Understanding the real-world application of T2T criteria is crucial for improving patient outcomes and guiding treatment decisions.

Data Highlights

No numerical data provided in the source material.

Key Findings

• 73.3% of patients achieved treatment targets as per Canadian T2T criteria.
• 98.4% of patients who met targets continued their biologic therapy.
• Nearly half of patients not meeting targets remained on treatment, influenced by DLQI and shared decision-making.
• The study underscores the importance of individualized care in psoriasis management.
• Canadian T2T criteria incorporate both objective measures and patient-reported outcomes.

Clinical Implications

Clinicians should consider both clinical and patient-reported outcomes when assessing treatment success in psoriasis. The findings highlight the need for personalized treatment strategies, especially for patients who do not meet predefined targets.

Conclusion

Strengthen the conclusion by linking it to broader implications in psoriasis management.

References

1. Canadian Treat-to-Target Practice Survey of Real-World Interventions and Strategies in Psoriasis, Dermatology and Therapy, 2026 -- Survey on Real-World Interventions and Strategies for Treat-to-Target Approaches in Psoriasis Management in Canada
2. Drugs - Real World Outcomes — Addressing Unmet Personal Needs in Psoriasis Patients with Low Disease Activity Treated with Adalimumab, Etanercept, or Ustekinumab
3. Drugs - Real World Outcomes — Insights into Patient Perspectives on Psoriatic Disease in the United States: Findings from the Psoriasis and Beyond Global Research Initiative
4. Drugs - Real World Outcomes — Patterns of Treatment and Drug Utilization Among Psoriasis Patients: An Observational Analysis in an Italian Clinical Environment
5. Drugs - Real World Outcomes — Impact of Biologic and Non-Biologic Therapies on Dermatology Life Quality Index Scores in Psoriasis Patients in Malaysia: A Retrospective Cross-Sectional Analysis
6. S3 Guideline for the treatment of psoriasis vulgaris, adapted from EuroGuiDerm – part 1: Treatment recommendations and monitoring
7. Which medicines, taken by mouth or injected, work best to treat plaque psoriasis?
8. Canadian Treat-to-Target Practice Survey of Real-World Interventions and Strategies in Psoriasis (CAN TARGET PSORIASIS) | Dermatology and Therapy | Springer Nature Link